• Profile
Close

Mortality in STEMI patients without standard modifiable risk factors: A gender-disaggregated analysis of SWEDEHEART registry data

The Lancet Mar 16, 2021

Figtree GA, Vernon ST, Hadziosmanovic N, et al. - Prevention strategies targeting standard modifiable cardiovascular risk factors (SMuRFs; hypertension, diabetes, hypercholesterolaemia, and smoking) are vital in cardiovascular disease, but myocardial infarction is not uncommon in the absence of SMuRFs. Researchers reported on the outcomes of those presenting with ST-elevation myocardial infarction (STEMI) without SMuRFs. Using data from the Swedish myocardial infarction registry SWEDEHEART, they retrospectively assessed adult patients with first-presentation STEMI. Among 62,048 patients with STEMI reported between January 1, 2005 and May 25, 2018, there were 9,228 (14.9%) who had no SMuRFs at diagnostic thresholds. A comparable rate of percutaneous coronary intervention was seen in SMuRF-less patients vs those with at least one, but at discharge they were significantly less likely to be taking statins, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockade (ARB), or β-blockers. All-cause mortality was significantly higher in SMuRF-less patients by 30 days after presentation, with SMuRF-less women having the highest 30-day mortality, followed by women with SMuRFs, SMuRF-less men, and men with SMuRFs. All-cause mortality was still higher in the SMuRF-less group for more than 8 years in men and up to 12 years in women. Findings revealed significantly higher risk of all-cause mortality in those with STEMI and no SMuRFs vs those with at least one; this was especially evident in women. Following adjustment for use of guideline-indicated treatments, the higher early mortality rates were lower, underscoring how evidence-based pharmacotherapy is needed immediately post infarct, even if the risk is perceived as low.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay